Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

<p>Abstract</p> <p>Introduction</p> <p>While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, dat...

Full description

Bibliographic Details
Main Authors: Chorostowska-Wynimko J, Zaleska J, Chabowski M, Szpechcinski A, Zych J, Rudzinski P, Langfort R, Orlowski T, Roszkowski-Sliz K
Format: Article
Language:English
Published: BMC 2009-12-01
Series:European Journal of Medical Research
Subjects:
lung cancer
neoadjuvant therapy
TGF-β
VEGF
sAPO-1
TIMP-1
Online Access:http://www.eurjmedres.com/content/14/S4/42

Internet

http://www.eurjmedres.com/content/14/S4/42

Similar Items